Nancy A. Dawson MD, Professor of Medicine at Lombardi Cancer Center shares on how to decide between combinations of immuno-oncology (I-O) and TKIs for treating 1st line renal cell carcinoma (RCC).
Advertisement
In the Treatment of 1st Line RCC: Selecting the Appropriate I-O and TKI combination
